LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $20,000 | +150.0% | 11,800 | +18.0% | 0.00% | – |
Q4 2021 | $8,000 | +100.0% | 10,000 | -23.1% | 0.00% | – |
Q3 2021 | $4,000 | -63.6% | 13,000 | +5.7% | 0.00% | – |
Q2 2021 | $11,000 | -88.7% | 12,300 | -75.3% | 0.00% | -100.0% |
Q1 2021 | $97,000 | +15.5% | 49,700 | -48.8% | 0.01% | +150.0% |
Q4 2020 | $84,000 | +4100.0% | 97,000 | +634.8% | 0.00% | – |
Q3 2020 | $2,000 | -93.8% | 13,200 | -70.3% | 0.00% | -100.0% |
Q1 2020 | $32,000 | +6.7% | 44,500 | +22.3% | 0.00% | 0.0% |
Q4 2019 | $30,000 | +76.5% | 36,400 | -8.8% | 0.00% | +100.0% |
Q3 2019 | $17,000 | +240.0% | 39,900 | +110.0% | 0.00% | – |
Q2 2019 | $5,000 | +150.0% | 19,000 | +57.0% | 0.00% | – |
Q1 2019 | $2,000 | -99.9% | 12,100 | -96.2% | 0.00% | -100.0% |
Q4 2018 | $1,541,000 | +151.4% | 319,237 | +47.5% | 0.10% | +148.7% |
Q3 2018 | $613,000 | -73.9% | 216,462 | -48.3% | 0.04% | -64.9% |
Q3 2017 | $2,346,000 | +234500.0% | 418,978 | +4089.8% | 0.11% | – |
Q3 2016 | $1,000 | -80.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |